Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKBC.L Regulatory News (KBC)

  • There is currently no data for KBC

Director/PDMR Shareholding

23 Sep 2015 12:21

RNS Number : 9649Z
KBC Advanced Technologies plc
23 September 2015
 

23 September 2015

 

 

KBC Advanced Technologies plc

 

Director's Dealings & DTR disclosure

 

KBC Advanced Technologies plc (the "Company" or "KBC") received notification today from Kestrel Partners LLP ("Kestrel") that on 22 September 2015 it acquired, on behalf of its discretionary clients, 200,000 ordinary shares in the Company at a price of £1.10 per share.

 

Kestrel is the investment manager to Kestrel Opportunities, a cell of Guernsey Portfolios PCC Limited ("Kestrel Opportunities"), and various other clients. This disclosure relates to indirect shares and voting rights in the Company that are managed by Kestrel on a discretionary basis.

 

Oliver Scott (Non-Executive Director of KBC) is a partner of, and holds a beneficial interest in, Kestrel. Mr Scott is also a shareholder in Kestrel Opportunities and is therefore deemed to have a legal beneficial interest in Kestrel Opportunities' entire legal holding in KBC.

 

Prior to this purchase of shares, Kestrel on a combined basis indirectly held shares and voting rights over 12,524,981 ordinary shares in the Company.

 

Following this transaction, Kestrel Opportunities holds (and consequently Mr Scott is deemed to have a legal beneficial interest in) 10,830,050 ordinary shares in the Company. Kestrel's other discretionary clients, in which Mr Scott has no legal beneficial interest, hold a further 1,894,931 ordinary shares in the Company.

 

On a combined basis, Kestrel indirectly holds voting rights over 12,724,981 ordinary shares in the Company, which represents approximately 15.43 per cent of the Company's issued share capital.

 

Save as disclosed above, Mr Scott has no interest in any further shares in KBC, either directly or indirectly.

 

Kestrel's interest in KBC is held through the following nominees:

 

Holding type

Nominee

No. of shares

% of issued share capital

Indirect

BNY Mellon a/c (Butterfield Bank Guernsey Limited)

10,830,050

13.13%

Indirect

JIM Nominees Limited

1,282,431

1.55%

 

 

 

 

Indirect

Bank of New York Nominees Ltd

612,500

0.74%

 

- ENDS -

Enquiries

 

KBC Advanced Technologies plc

 

Janet Ireland, Company Secretary

Tel 01932 242424

Cenkos Securities plc

 

Bobbie Hilliam

Tel 020 7397 8900

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSSEUFFDFISEFU
Date   Source Headline
28th Mar 20139:56 amRNSDirector/PDMR Shareholding
26th Mar 20137:00 amRNSFinal Results
8th Mar 201310:45 amRNSNotice of Results
4th Feb 20132:41 pmRNSTotal Voting Rights
28th Jan 20139:55 amRNSDirector/PDMR Shareholding
28th Jan 20139:22 amRNSHolding(s) in Company
28th Jan 20139:17 amRNSHolding(s) in Company
25th Jan 201311:39 amRNSDirector/PDMR Shareholding
24th Jan 20137:00 amRNSPre-close Trading Update
8th Jan 20132:52 pmRNSHolding(s) in Company
27th Dec 201211:08 amRNSDirector/PDMR Shareholding
21st Dec 201211:38 amRNSDirector/PDMR Shareholding
19th Dec 20127:00 amRNSUS$100 million Contract Award
3rd Dec 20129:31 amRNSTotal Voting Rights
25th Oct 201210:44 amRNSDirector/PDMR Shareholding
23rd Oct 201212:40 pmRNSDirector/PDMR Shareholding
16th Oct 20128:56 amRNSHolding(s) in Company
15th Oct 20129:29 amRNSDirector/PDMR Shareholding
10th Oct 201210:45 amRNSHolding(s) in Company
10th Oct 20129:21 amRNSDirector/PDMR Shareholding
9th Oct 20122:04 pmRNSBlocklisting Interim Review
9th Oct 20129:39 amRNSHolding(s) in Company
8th Oct 201212:21 pmRNSDirector/PDMR Shareholding
5th Oct 20127:00 amRNSBoard Changes
2nd Oct 20124:04 pmRNSCompletion of cash subscription
28th Sep 20122:56 pmRNSHolding(s) in Company
28th Sep 201210:41 amRNSDirector/PDMR Shareholding
26th Sep 20127:00 amRNSDirector/PDMR Shareholding
25th Sep 20127:00 amRNSHalf Year Results and Cash Subscription
20th Sep 20127:00 amRNSAppointment of Director & Chief Financial Officer
12th Sep 20123:30 pmRNSNotice of Results
13th Aug 201210:57 amRNSHolding(s) in Company
1st Aug 20129:18 amRNSTotal Voting Rights
24th Jul 20127:00 amRNSTrading Update and Confirmation of Board Changes
18th Jul 201210:00 amRNSHolding(s) in Company
2nd Jul 20123:44 pmRNSTotal Voting Rights
21st Jun 20127:00 amRNSDirector/PDMR Shareholding
19th Jun 20127:00 amRNSAcquisition of Infochem
31st May 20123:39 pmRNSTotal Voting Rights
9th May 20124:56 pmRNSAGM Statement
9th May 20127:00 amRNSAGM Statement
1st May 201211:50 amRNSTotal Voting Rights
11th Apr 20124:58 pmRNSBlocklisting Interim Review
11th Apr 20124:48 pmRNSBlocklisting Interim Review
10th Apr 201210:00 amRNSAnnual Financial Report
13th Mar 20127:00 amRNSFinal Results
5th Mar 20124:00 pmRNSNotice of Results
2nd Feb 201210:21 amRNSTotal Voting Rights
23rd Jan 20121:42 pmRNSHolding(s) in Company
16th Jan 20129:41 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.